Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7312753

COc1c(CCN)c2cc(-c3cccc(C#N)c3)ccc2n1Cc1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.39
PLA2G2A P14555 3/20 0.38
ALOX5AP P20292 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
PPARG P37231 1/20 0.37
RXRA P19793 1/20 0.36
RXRG P48443 1/20 0.36
SLC2A1 P11166 1/20 0.36
PTGES2 Q9H7Z7 6/20 0.36
SERPINE1 P05121 1/20 0.36
ADAM17 P78536 1/20 0.36
PTPN5 P54829 1/20 0.36
PTGES O14684 2/20 0.35
TBXAS1 P24557 1/20 0.35
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7314734 0.92 AR (0.38) PLA2G2AALOX5APPPARGSLC2A1PTGES2
Trifluoroacetic Acid SCHEMBL7315970 0.91 CCR2 (0.41) PLA2G2AALOX5APGRIN1GRIN2BSLC2A1
Trifluoroacetic Acid SCHEMBL7318205 0.88 ICMT (0.41) PLA2G2AGRIN1GRIN2BPPARG
Trifluoroacetic Acid SCHEMBL7316949 0.83 ABCB11 (0.40) PLA2G2AGRIN1GRIN2BPTGES2ADAM17
Trifluoroacetic Acid SCHEMBL7585777 0.83 EGFR (0.46) PLA2G2AALOX5APPPARG
Trifluoroacetic Acid SCHEMBL7403856 0.71 PTGDR2 (0.40) MDM2PTGDR2RXRARXRGSLC2A1
Trifluoroacetic Acid SCHEMBL7315177 0.68 EGFR (0.54) PLA2G2APPARG
Trifluoroacetic Acid SCHEMBL7320899 0.66 SERPINE1 (0.33) PTGDR2PPARGSERPINE1
Trifluoroacetic Acid SCHEMBL3750230 0.66 FFAR1 (0.49) SLC2A1
Trifluoroacetic Acid SCHEMBL27502598 0.64 FFAR1 (0.52) PTGDR2RXRARXRGPTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US claimed
US-20020004198-A1 Novel anti-infectives SMITHKLINE BEECHAM CORPORATION 2002-01-10 US disclosed
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US disclosed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010007877-A1 NOVEL ANTI-INFECTIVES CTSL, MMP8, SERPINB1 MDM2 4182/4885PLA2G2A 2102/4885ALOX5AP 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.